Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.
At INITIO CELL, we develop patented multi-functional organ-on-a-chip devices and assays for drug discovery and diagnostics.
Classical drug discovery uses 2D cell culture coupled with animal testing for preclinical studies. Neither 2D cell culture nor animal testing truly recapitulate the in vivo micro environments of cells in a human body. The paradigm shift is to use 3D cell culture in organ-on-a- chip devices that can faithfully mimic the in vivo conditions. Using organ-on- chip technology is expected to reduce R&D costs (186 B $ in 2020) by 26%.